ADMA Biologics (ADMA) Insider buying
4 open-market purchases of ADMA by ADMA Biologics's executives and directors since March 2026, worth $360,564 in total, from SEC Form 4 filings.
Summary
The most recent: Jerrold B Grossman, Director bought $50,624 on May 27, 2026.
The biggest buyer over the period is Jerrold B Grossman (Director): 3 purchases, $250,874.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 4 | $360,564 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Jerrold B Grossman Director | 3 | $250,874 |
| Steve Elms | 1 | $109,690 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
Questions about ADMA Biologics
Are ADMA Biologics insiders buying the stock?
4 open-market purchases of ADMA by ADMA Biologics's executives and directors since March 2026, worth $360,564 in total, from SEC Form 4 filings. The most recent: Jerrold B Grossman, Director bought $50,624 on May 27, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From ADMA Biologics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.